ACADIA HEALTHCARE COMPANY, INC. 00404A109 US00404A1097 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 269582 0 FOR 269582 FOR ACADIAN ASSET MANAGEMENT INC. 10948W103 US10948W1036 06/11/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 84000 0 FOR 84000 FOR ADAPTIVE BIOTECHNOLOGIES CORPORATION 00650F109 US00650F1093 06/05/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; SECTION 14A SAY-ON-PAY VOTES 10006 0 FOR 10006 FOR AGIOS PHARMACEUTICALS, INC. 00847X104 US00847X1046 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 4562559 0 FOR 4562559 FOR AKERO THERAPEUTICS, INC 00973Y108 US00973Y1082 12/02/2025 To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES 414744 0 FOR 414744 FOR ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 20800 0 FOR 20800 FOR ALTIMMUNE INC. 02155H200 US02155H2004 09/25/2025 Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 27069 0 FOR 27069 FOR AMAZON.COM, INC. 023135106 US0231351067 05/20/2026 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION SECTION 14A SAY-ON-PAY VOTES 4658394 0 FOR 4658394 FOR AMICUS THERAPEUTICS, INC. 03152W109 US03152W1099 03/03/2026 To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES 16000 0 FOR 16000 FOR AON PLC G0403H108 IE00BLP1HW54 06/26/2026 Advisory resolution to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2131670 0 FOR 2131670 FOR ARAMARK 03852U106 US03852U1060 02/03/2026 To approve, in a non-binding advisory vote, the compensation paid to the named executive officers. SECTION 14A SAY-ON-PAY VOTES 5923179 0 FOR 5923179 FOR ARCUS BIOSCIENCES, INC. 03969F109 US03969F1093 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 123 0 AGAINST 123 AGAINST ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 US03969K1088 06/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2 0 FOR 2 FOR ARDELYX, INC 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); SECTION 14A SAY-ON-PAY VOTES 15458 0 FOR 15458 FOR ARDELYX, INC 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on- Pay vote should occur every one (1) year, every two (2) years or every three (3) years; SECTION 14A SAY-ON-PAY VOTES 15458 0 FOR 15458 FOR ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/19/2026 Advisory Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES 2957 0 FOR 2957 FOR ARVINAS, INC. 04335A105 US04335A1051 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 3261 0 FOR 3261 FOR ASSEMBLY BIOSCIENCES, INC. 045396207 US0453962070 06/04/2026 Approval, on a non-binding advisory basis, of our named executive officers' compensation. SECTION 14A SAY-ON-PAY VOTES 1227590 0 FOR 1227590 FOR AVIDITY BIOSCIENCES, INC. 05370A108 US05370A1088 02/26/2026 To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. SECTION 14A SAY-ON-PAY VOTES 3233000 0 FOR 3233000 FOR AXSOME THERAPEUTICS, INC. 05464T104 US05464T1043 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 45 0 FOR 45 FOR BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 6441267 0 FOR 6441267 FOR BEONE MEDICINES, LTD. (FKA BEIGENE) 07725L102 US07725L1026 06/11/2026 THAT, - on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, for the fiscal year ended December 31, 2025 be and is hereby approved. SECTION 14A SAY-ON-PAY VOTES 13 0 FOR 13 FOR BEYOND MEAT, INC. 08862E109 US08862E1091 05/20/2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 262 0 AGAINST 262 AGAINST BIOCRYST PHARMACEUTICALS, INC. 09058V103 US09058V1035 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES 6066 0 FOR 6066 FOR BIODESIX, INC. 09075X207 US09075X2071 05/19/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES 5964 0 FOR 5964 FOR BIODESIX, INC. 09075X207 US09075X2071 05/19/2026 To approve, on a non-binding advisory basis, the frequency of solicitation of advisory votes to approve named executive officer compensation; SECTION 14A SAY-ON-PAY VOTES 5964 0 FOR 5964 FOR BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 5559272 0 FOR 5559272 FOR BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 5740639 0 FOR 5740639 FOR BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 5740639 0 FOR 5740639 FOR BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES 1048839 0 FOR 1048839 FOR BROADCOM INC 11135F101 US11135F1012 04/20/2026 Advisory vote to approve the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 1045775 0 FOR 1045775 FOR C4 THERAPEUTICS, INC. 12529R107 US12529R1077 06/24/2026 To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 23321 0 FOR 23321 FOR CANOPY GROWTH CORPORATION 138035704 CA1380357048 10/10/2025 To adopt, on an advisory (non-binding) basis, a resolution approving the compensation of the Company's named executive officers, as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 6 0 AGAINST 6 AGAINST CAPRICOR THERAPEUTICS, INC. 14070B309 US14070B3096 06/04/2026 APPROVAL OF A NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS SECTION 14A SAY-ON-PAY VOTES 29115 0 FOR 29115 FOR CAPRICOR THERAPEUTICS, INC. 14070B309 US14070B3096 06/04/2026 APPROVAL OF FREQUENCY OF FUTURE NON-BINDING ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS SECTION 14A SAY-ON-PAY VOTES 29115 0 FOR 29115 FOR CARDINAL HEALTH, INC. 14149Y108 US14149Y1082 11/05/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 57040 0 FOR 57040 FOR CECO ENVIRONMENTAL CORP. 125141101 US1251411013 05/27/2026 To approve, on an advisory basis, the compensation of CECO's named executive officers. SECTION 14A SAY-ON-PAY VOTES 473 0 FOR 473 FOR CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To approve, on an advisory basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 3750 0 FOR 3750 FOR CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 1466071 0 FOR 1466071 FOR CENCORA, INC. 03073E105 US03073E1055 03/05/2026 Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES 1000 0 FOR 1000 FOR CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES 1330901 0 FOR 1330901 FOR CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 400 0 FOR 400 FOR CITIGROUP INC. 172967424 US1729674242 05/20/2026 Advisory vote to approve our 2025 Executive Compensation. SECTION 14A SAY-ON-PAY VOTES 47000 0 FOR 47000 FOR COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2202 0 FOR 2202 FOR CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; SECTION 14A SAY-ON-PAY VOTES 5647188 0 FOR 5647188 FOR DIANTHUS THERAPEUTICS, INC. 252828108 US2528281080 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES 456711 0 FOR 456711 FOR DISC MEDICINE, INC. 254604101 US2546041011 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1981 0 FOR 1981 FOR DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 121 0 FOR 121 FOR ELECTRONIC ARTS INC. 285512109 US2855121099 12/22/2025 To consider and vote on a proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the transactions contemplated by the merger agreement, including consummation of the merger. SECTION 14A SAY-ON-PAY VOTES 0 0 Not Voted 0 NONE ENANTA PHARMACEUTICALS, INC. 29251M106 US29251M1062 03/11/2026 To approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 2772195 0 FOR 2772195 FOR ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 4990 0 FOR 4990 FOR ENLIVEN THERAPEUTICS, INC. 29337E102 US29337E1029 06/09/2026 To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES 4025 0 AGAINST 4025 AGAINST ENLIVEN THERAPEUTICS, INC. 29337E102 US29337E1029 06/09/2026 To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 4025 0 FOR 4025 FOR ESTABLISHMENT LABS HOLDINGS INC. G31249108 VGG312491084 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES 2482 0 FOR 2482 FOR EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Proposal to approve the compensation of our named executive officers for 2025 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES 14000 0 FOR 14000 FOR EXACT SCIENCES CORPORATION 30063P105 US30063P1057 02/20/2026 Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Exact Sciences Corporation's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES 6405000 0 FOR 6405000 FOR EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 7505618 0 AGAINST 7505618 AGAINST EXLSERVICE HOLDINGS, INC. 302081104 US3020811044 06/16/2026 The approval, on a non-binding advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 17757 0 FOR 17757 FOR EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES 4914 0 FOR 4914 FOR FISERV, INC. 337738108 US3377381088 05/21/2026 To approve, on an advisory basis, the compensation of the named executive officers of Fiserv, Inc. SECTION 14A SAY-ON-PAY VOTES 7530 0 FOR 7530 FOR FORMFACTOR, INC. 346375108 US3463751087 05/15/2026 Advisory approval of FormFactor's executive compensation. SECTION 14A SAY-ON-PAY VOTES 3704 0 FOR 3704 FOR GARRETT MOTION INC. 366505105 US3665051054 05/28/2026 The approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 229962 0 FOR 229962 FOR GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 3826 0 FOR 3826 FOR GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES 3826 0 FOR 3826 FOR GERON CORPORATION 374163103 US3741631036 05/20/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 163 0 FOR 163 FOR GLAUKOS CORPORATION 377322102 US3773221029 05/28/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2146 0 AGAINST 2146 AGAINST GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 1519 0 FOR 1519 FOR GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1519 0 FOR 1519 FOR HEALTHCARE REALTY TRUST INCORPORATED 42226K105 US42226K1051 05/19/2026 To approve, on a non-binding advisory basis, the following resolution: SECTION 14A SAY-ON-PAY VOTES 96 0 FOR 96 FOR HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1 0 FOR 1 FOR HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES 116 0 AGAINST 116 AGAINST ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1400 0 FOR 1400 FOR IDEAYA BIOSCIENCES, INC. 45166A102 US45166A1025 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; SECTION 14A SAY-ON-PAY VOTES 28 0 FOR 28 FOR IMMUNOVANT, INC. 45258J102 US45258J1025 08/27/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 8704 0 FOR 8704 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 17 0 FOR 17 FOR INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 17 0 FOR 17 FOR INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 2627 0 FOR 2627 FOR INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 14 0 FOR 14 FOR IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. SECTION 14A SAY-ON-PAY VOTES 863 0 FOR 863 FOR JANUX THERAPEUTICS, INC. 47103J105 US47103J1051 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 3051 0 AGAINST 3051 AGAINST JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES 131000 0 FOR 131000 FOR KODIAK SCIENCES INC. 50015M109 US50015M1099 06/02/2026 Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 4143 0 FOR 4143 FOR KRYSTAL BIOTECH, INC. 501147102 US5011471027 05/15/2026 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES 1552 0 FOR 1552 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the compensation paid to our named executive officers (commonly referred to as ''say on pay''). SECTION 14A SAY-ON-PAY VOTES 3916259 0 FOR 3916259 FOR LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the frequency of holding future ''say on pay'' votes. SECTION 14A SAY-ON-PAY VOTES 3916259 0 FOR 3916259 FOR LIQUIDIA CORPORATION 53635D202 US53635D2027 06/16/2026 To approve, on an non-binding basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 6673825 0 FOR 6673825 FOR LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("U.S. Say on Pay"). SECTION 14A SAY-ON-PAY VOTES 54 0 FOR 54 FOR MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES 2639 0 FOR 2639 FOR MASIMO CORPORATION 574795100 US5747951003 05/01/2026 To consider and vote on the proposal to approve, on a non- binding, advisory basis, the compensation that may be paid or become payable to Masimo's named executive officers that is based on or otherwise relates to the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES 1000 0 FOR 1000 FOR MASTERCARD INCORPORATED 57636Q104 US57636Q1040 06/16/2026 Advisory approval of Mastercard's executive compensation SECTION 14A SAY-ON-PAY VOTES 452471 0 FOR 452471 FOR MCKESSON CORPORATION 58155Q103 US58155Q1031 07/30/2025 Advisory Vote to Approve the Company's Executive Compensation SECTION 14A SAY-ON-PAY VOTES 334000 0 FOR 334000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Advisory Vote to Approve Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES 3000 0 FOR 3000 FOR MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Advisory Vote on the Frequency of Votes on Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES 3000 0 FOR 3000 FOR MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 445000 0 FOR 445000 FOR MERIT MEDICAL SYSTEMS, INC. 589889104 US5898891040 05/13/2026 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 3000 0 FOR 3000 FOR MERUS N.V. N5749R100 NL0011606264 12/09/2025 Non-binding advisory proposal to approve certain compensation arrangements SECTION 14A SAY-ON-PAY VOTES 3000 0 AGAINST 3000 AGAINST MICROSOFT CORPORATION 594918104 US5949181045 12/05/2025 Advisory Vote to Approve Named Executive Officer Compensation (''say-on-pay vote'') SECTION 14A SAY-ON-PAY VOTES 1962135 0 FOR 1962135 FOR MINERVA NEUROSCIENCES, INC. 603380205 US6033802058 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES 2365000 0 AGAINST 2365000 AGAINST MINERVA NEUROSCIENCES, INC. 603380205 US6033802058 06/03/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2365000 0 FOR 2365000 FOR MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 79 0 FOR 79 FOR NATERA, INC. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 2900012 0 FOR 2900012 FOR NATERA, INC. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 2900012 0 FOR 2900012 FOR NEKTAR THERAPEUTICS 640268306 US6402683063 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). SECTION 14A SAY-ON-PAY VOTES 3491 0 FOR 3491 FOR NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 38 0 AGAINST 38 AGAINST NOVAVAX, INC. 670002401 US6700024010 06/18/2026 The approval, on an advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 231 0 FOR 231 FOR NUVALENT, INC. 670703107 US6707031075 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 24 0 FOR 24 FOR NUVATION BIO INC. 67080N101 US67080N1019 05/21/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 2306 0 FOR 2306 FOR OCULAR THERAPEUTIX, INC. 67576A100 US67576A1007 06/10/2026 To approve an advisory vote on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 11684 0 AGAINST 11684 AGAINST OCULAR THERAPEUTIX, INC. 67576A100 US67576A1007 06/10/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 11684 0 FOR 11684 FOR OMEROS CORPORATION 682143102 US6821431029 06/18/2026 Approval of advisory resolution on executive compensation. SECTION 14A SAY-ON-PAY VOTES 106 0 FOR 106 FOR PIPER SANDLER COMPANIES 724078209 US7240782091 05/20/2026 An advisory (non-binding) vote to approve the compensation of the officers disclosed in the enclosed proxy statement, or say-on-pay vote. SECTION 14A SAY-ON-PAY VOTES 14707 0 FOR 14707 FOR PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Company Proposal - Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 34004 0 FOR 34004 FOR PRIVIA HEALTH GROUP, INC. 74276R102 US74276R1023 05/20/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers (''NEOs''). SECTION 14A SAY-ON-PAY VOTES 1327 0 FOR 1327 FOR PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers SECTION 14A SAY-ON-PAY VOTES 929 0 FOR 929 FOR PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 4779080 0 FOR 4779080 FOR PROTHENA CORPORATION PLC G72800108 IE00B91XRN20 05/14/2026 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES 3200 0 FOR 3200 FOR REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES 14135270 0 FOR 14135270 FOR ROIVANT SCIENCES LTD. G76279101 BMG762791017 09/10/2025 To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 7397 0 AGAINST 7397 AGAINST ROYALTY PHARMA PLC G7709Q104 GB00BMVP7Y09 06/04/2026 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 493000 0 FOR 493000 FOR SABRA HEALTH CARE REIT, INC. 78573L106 US78573L1061 06/17/2026 Approval, on an advisory basis, of the compensation of Sabra's named executive officers. SECTION 14A SAY-ON-PAY VOTES 8510 0 FOR 8510 FOR SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 241 0 AGAINST 241 AGAINST SELLAS LIFE SCIENCES GROUP, INC. 81642T209 US81642T2096 06/16/2026 The advisory approval of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 40000 0 FOR 40000 FOR SEMLER SCIENTIFIC, INC. 81684M104 US81684M1045 09/05/2025 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 188 0 FOR 188 FOR SEMLER SCIENTIFIC, INC. 81684M104 US81684M1045 01/13/2026 To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to the named executive officers of Semler Scientific that arises from or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES 2242 0 FOR 2242 FOR SERVICENOW, INC. 81762P102 US81762P1021 05/21/2026 Advisory vote to approve ServiceNow's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 546 0 FOR 546 FOR SERVICENOW, INC. 81762P102 US81762P1021 05/21/2026 Advisory vote on the frequency of future advisory votes on executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 546 0 FOR 546 FOR SPRUCE BIOSCIENCES, INC. 85209E208 US85209E2081 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 881 0 AGAINST 881 AGAINST SPRUCE BIOSCIENCES, INC. 85209E208 US85209E2081 05/21/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 881 0 FOR 881 FOR STOKE THERAPEUTICS, INC. 86150R107 US86150R1077 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1784 0 FOR 1784 FOR STRUCTURE THERAPEUTICS, INC. 86366E106 US86366E1064 06/17/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 2801 0 FOR 2801 FOR SUMMIT MIDSTREAM CORPORATION 86614G101 US86614G1013 05/07/2026 Approval of Advisory Resolution on Executive Compensation. SECTION 14A SAY-ON-PAY VOTES 58214 0 FOR 58214 FOR SUPERNUS PHARMACEUTICALS, INC. 868459108 US8684591089 06/18/2026 To approve, on a non-binding basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1623 0 FOR 1623 FOR SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES 7143 0 FOR 7143 FOR SYNOPSYS, INC. 871607107 US8716071076 04/16/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 1152904 0 FOR 1152904 FOR TANGO THERAPEUTICS, INC. 87583X109 US87583X1090 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 7375577 0 FOR 7375577 FOR TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. SECTION 14A SAY-ON-PAY VOTES 29 0 FOR 29 FOR TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 To approve, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES 191986 0 AGAINST 191986 AGAINST TEVA PHARMACEUTICAL INDUSTRIES LIMITED 881624209 US8816242098 05/28/2026 TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION FOR TEVA'S NAMED EXECUTIVE OFFICERS SECTION 14A SAY-ON-PAY VOTES 17376 0 FOR 17376 FOR THE CHARLES SCHWAB CORPORATION 808513105 US8085131055 05/21/2026 Advisory approval of named executive officer compensation SECTION 14A SAY-ON-PAY VOTES 4209955 0 FOR 4209955 FOR THE WALT DISNEY COMPANY 254687106 US2546871060 03/18/2026 Consideration of an advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 2494208 0 FOR 2494208 FOR THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 706152 0 FOR 706152 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1661 0 FOR 1661 FOR TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1661 0 FOR 1661 FOR TWIST BIOSCIENCE CORPORATION 90184D100 US90184D1000 02/05/2026 To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under ''Executive Compensation.'' SECTION 14A SAY-ON-PAY VOTES 4994 0 FOR 4994 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 664 0 FOR 664 FOR UNIQURE N.V. N90064101 NL0010696654 06/10/2026 Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 664 0 FOR 664 FOR UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES 1828106 0 FOR 1828106 FOR UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES 7599 0 FOR 7599 FOR VAXCYTE, INC. 92243G108 US92243G1085 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 6961 0 FOR 6961 FOR VERTIV HOLDINGS CO 92537N108 US92537N1081 06/17/2026 To approve, on an advisory basis, the 2025 compensation of our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 34 0 FOR 34 FOR VIKING THERAPEUTICS INC 92686J106 US92686J1060 05/19/2026 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES 174 0 FOR 174 FOR VIR BIOTECHNOLOGY, INC. 92764N102 US92764N1028 05/26/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 12124 0 AGAINST 12124 AGAINST VISA INC. 92826C839 US92826C8394 01/27/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 464251 0 FOR 464251 FOR WELLTOWER INC. 95040Q104 US95040Q1040 05/21/2026 The approval, on an advisory basis, of the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES 200000 0 AGAINST 200000 AGAINST WESTERN ALLIANCE BANCORPORATION 957638109 US9576381092 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of executives. SECTION 14A SAY-ON-PAY VOTES 57838 0 FOR 57838 FOR WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP 929740108 US9297401088 05/12/2026 Approve an advisory (non-binding) resolution to approve the 2025 named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 1732799 0 FOR 1732799 FOR